logo
Select company
Select metric
$ -60.1MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
11
Sector
28
Industry
41
History
20
$ 1.37Close
$ 0.65 - $ 1.97 52-Week Range
Ticker Information

Ticker

BRNS

Company Name

BARINTHUS BIOTHERAPEUTICS PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BARINTHUS BIOTHERAPEUTICS PLC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BRNS - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 9.32M$ -69.42M$ -60.1M
3/31/2025$ 8.3M$ -65.21M$ -56.91M
12/31/2024$ 7.24M$ -61.06M$ -53.82M
9/30/2024$ 7.43M$ -58.65M$ -51.21M
6/30/2024$ 7.26M$ -65.21M$ -57.96M
3/31/2024$ 7.05M$ -73.21M$ -66.17M
12/31/2023$ 6.76M$ -76.39M$ -69.64M
9/30/2023$ 6.39M$ -81.47M$ -75.09M
6/30/2023$ 6.17M$ -59.25M$ -53.08M
3/31/2023$ 6.07M$ -19.61M$ -13.54M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • BARINTHUS BIOTHERAPEUTICS PLC's latest trailing twelve months (TTM) EBITDA stands at $ -13.8M.
  • Over the past 5 years, BARINTHUS BIOTHERAPEUTICS PLC's average EBITDA has been $ -39.48M.
  • The median EBITDA for BARINTHUS BIOTHERAPEUTICS PLC during this period was $ -52.15M
  • BARINTHUS BIOTHERAPEUTICS PLC reached its highest EBITDA over the past 5 years at $ 13.27M.
  • The lowest EBITDA recorded by BARINTHUS BIOTHERAPEUTICS PLC in the same timeframe $ -75.09M

BARINTHUS BIOTHERAPEUTICS PLC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
VRCA : VERRICA PHARMACEUTICALS INC $ -38.54MEQ : EQUILLIUM INC $ -19.7MIRD : OPUS GENETICS INC $ -58.24MXLO : XILIO THERAPEUTICS INC $ -54.59MHYFT : MINDWALK HOLDINGS CORP $ -19.99MCUE : CUE BIOPHARMA INC $ -36.06MOVID : OVID THERAPEUTICS INC $ -36.47MSRZN : SURROZEN INC $ -31.83MPSTV : PLUS THERAPEUTICS INC $ -14.57MVERU : VERU INC $ -31.9M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for BARINTHUS BIOTHERAPEUTICS PLC is calculated as follows: EBIT [ $ -14.01M ] + DepAmor [ $ 208.4K ]
(=) EBITDA [ $ -13.8M ]

BRNS - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -75.09M

Minimum

Sep 30, 2023

$ 13.27M

Maximum

Sep 30, 2022

$ -39.48M

Average

$ -52.15M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.77M with a standard deviation of $ 166.95M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.77M
median$ 8.83M
std$ 166.95M